E. Michael Lewiecki

31.9k total citations · 11 hit papers
289 papers, 20.7k citations indexed

About

E. Michael Lewiecki is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, E. Michael Lewiecki has authored 289 papers receiving a total of 20.7k indexed citations (citations by other indexed papers that have themselves been cited), including 245 papers in Orthopedics and Sports Medicine, 153 papers in Oncology and 92 papers in Molecular Biology. Recurrent topics in E. Michael Lewiecki's work include Bone health and osteoporosis research (241 papers), Bone health and treatments (151 papers) and Bone Metabolism and Diseases (90 papers). E. Michael Lewiecki is often cited by papers focused on Bone health and osteoporosis research (241 papers), Bone health and treatments (151 papers) and Bone Metabolism and Diseases (90 papers). E. Michael Lewiecki collaborates with scholars based in United States, Canada and Belgium. E. Michael Lewiecki's co-authors include Meryl S. LeBoff, Felicia Cosman, Paul D. Miller, Susan Randall, Suzanne M. Jan de Beur, R. Lindsay, Michael R. McClung, Neil Binkley, Nelson B. Watts and Steven M. Petak and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

E. Michael Lewiecki

279 papers receiving 20.1k citations

Hit Papers

Clinician’s Guide to Prevention and Treatment of Ost... 2006 2026 2012 2019 2014 2016 2016 2006 2020 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinician’s Guide to Prevention and Treatment of Osteoporosis
    2014 2.6k citations Felicia Cosman, E. Michael Lewiecki et al. profile →
  2. Romosozumab Treatment in Postmenopausal Women with Osteoporosis
    2016 1.1k citations Felicia Cosman, Jonathan D. Adachi et al. profile →
  3. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016--Executive Summary
    2016 939 citations Neil Binkley, B.L. Clarke et al. profile →
  4. Denosumab in Postmenopausal Women with Low Bone Mineral Density
    2006 886 citations Michael R. McClung, E. Michael Lewiecki et al. profile →
  5. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis—2020 Update
    2020 659 citations Neil Binkley, E. Michael Lewiecki et al. profile →
  6. The clinician’s guide to prevention and treatment of osteoporosis
    2022 623 citations E. Michael Lewiecki, Kenneth G. Saag et al. profile →
  7. Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop
    2009 500 citations Shonni J. Silverberg, E. Michael Lewiecki et al. profile →
  8. Interpretation and use of FRAX in clinical practice
    2011 383 citations Cyrus Cooper, John P. Bilezikian et al. profile →
  9. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016
    2016 359 citations Neil Binkley, B.L. Clarke et al. profile →
  10. Executive Summary of the 2019 ISCD Position Development Conference on Monitoring Treatment, DXA Cross-calibration and Least Significant Change, Spinal Cord Injury, Peri-prosthetic and Orthopedic Bone Health, Transgender Medicine, and Pediatrics
    2019 337 citations E. Michael Lewiecki et al. Journal of Clinical Densitometry profile →
  11. Goal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024
    2024 33 citations Felicia Cosman, E. Michael Lewiecki et al. Journal of Bone and Mineral Research profile →

Peers

E. Michael Lewiecki
Felicia Cosman United States
Michael R. McClung United States
Ethel S. Siris United States
Dan Mellström Sweden
Eugène McCloskey United Kingdom
Nelson B. Watts United States
Jacques P. Brown Canada
Christian Roux France
Robert Lindsay United States
Paul D. Miller United States
Felicia Cosman United States
E. Michael Lewiecki
Citations per year, relative to E. Michael Lewiecki E. Michael Lewiecki (= 1×) peers Felicia Cosman

Countries citing papers authored by E. Michael Lewiecki

Since Specialization
Citations

This map shows the geographic impact of E. Michael Lewiecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Michael Lewiecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Michael Lewiecki more than expected).

Fields of papers citing papers by E. Michael Lewiecki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Michael Lewiecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Michael Lewiecki. The network helps show where E. Michael Lewiecki may publish in the future.

Co-authorship network of co-authors of E. Michael Lewiecki

This figure shows the co-authorship network connecting the top 25 collaborators of E. Michael Lewiecki. A scholar is included among the top collaborators of E. Michael Lewiecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Michael Lewiecki. E. Michael Lewiecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Maya, Rachel Pessah‐Pollack, & E. Michael Lewiecki. (2025). Bone Health ECHO Case Report: Is it Paget's Disease?. Journal of Clinical Densitometry. 28(1). 101550–101550.
2.
Eastell, Richard, Jacques P. Brown, Robert A. Adler, et al.. (2025). Bone turnover markers predict changes in bone mineral density in men treated with abaloparatide: results from the abaloparatide for the treatment of men with osteoporosis (ATOM) study. Journal of Bone and Mineral Research. 40(3). 315–322. 1 indexed citations
3.
Kushchayeva, Yevgeniya, et al.. (2024). Bone Health ECHO Case Report: Significant Elevation in Bone Turnover Markers and Progression of Vertebral Fractures After Denosumab Discontinuation Followed by a PTH-Analog. Journal of Clinical Densitometry. 28(1). 101551–101551. 1 indexed citations
4.
Lewiecki, E. Michael, et al.. (2024). Bone Health ECHO Case Report: Orbital Inflammation after Zoledronate Infusion. Journal of Clinical Densitometry. 27(4). 101519–101519.
5.
Lewiecki, E. Michael. (2024). Utility of Trabecular Bone Score in the Management of Patients with Osteoporosis. Endocrinology and Metabolism Clinics of North America. 53(4). 547–557. 2 indexed citations
6.
Lewiecki, E. Michael, Ludovic Humbert, Cesar Libanati, et al.. (2024). 3D-modeling from hip DXA shows improved bone structure with romosozumab followed by denosumab or alendronate. Journal of Bone and Mineral Research. 39(4). 473–483. 10 indexed citations
7.
Lewiecki, E. Michael, E. J. Czerwiński, Chris Recknor, et al.. (2023). Efficacy and Safety of Transdermal Abaloparatide in Postmenopausal Women with Osteoporosis: A Randomized Study. Journal of Bone and Mineral Research. 38(10). 1404–1414. 10 indexed citations
8.
Bilezikian, John P., Shonni J. Silverberg, Francisco Bandeira, et al.. (2020). Management of Primary Hyperparathyroidism. Journal of Bone and Mineral Research. 37(11). 2391–2403. 45 indexed citations
9.
Czerwiński, E. J., José Cardona, Chris Recknor, et al.. (2020). The Efficacy and Safety of Abaloparatide-SC in Men With Osteoporosis: A Randomized Clinical Trial. Journal of Bone and Mineral Research. 37(12). 2435–2442. 23 indexed citations
10.
Ferrari, Serge, S. Adámi, Jacques P. Brown, et al.. (2016). relationship between total hip BMD T-score and incidence of nonvertebral fracture with up to 10 years of Denosumab (DMAB) treatment. Open Repository and Bibliography (University of Liège). 1 indexed citations
11.
Ferrari, Serge, Cesar Libanati, S. Adámi, et al.. (2015). Relationship between total hip BMD T-score and incidence of nonvertebral fracture with up to 8 years of denosumab treatment. Open Repository and Bibliography (University of Liège). 5 indexed citations
12.
Papapoulos, Socrates E., C. Roux, Paula Dakin, et al.. (2015). Denosumab treatment in postmenopausal women with osteoporosis for up to 9 years: results through year 6 of the freedom extension. Open Repository and Bibliography (University of Liège). 2 indexed citations
13.
Papapoulos, Socrates E., Kurt Lippuner, C. Roux, et al.. (2014). EIGHT YEARS OF DENOSUMAB TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FIRST FIVE YEARS OF THE FREEDOM EXTENSION. Open Repository and Bibliography (University of Liège). 12 indexed citations
14.
Ferrari, Serge, Cesar Libanati, S. Adámi, et al.. (2014). Percentage of women achieving non-osteoporotic BMD T-scores at the spine and hip over 8 years of denosumab treatment. Open Repository and Bibliography (University of Liège). 1 indexed citations
15.
Ferrari, Serge, Kurt Lippuner, Carol Zapalowski, et al.. (2014). Further reduction in nonvertebral fracture rate is observed following 3 years of denosumab treatment: results with up to 7 years in the freedom extension. Open Repository and Bibliography (University of Liège). 4 indexed citations
16.
Silverberg, Shonni J., B.L. Clarke, Munro Peacock, et al.. (2014). Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. PMC. 1 indexed citations
17.
Khosla, Sundeep, John P. Bilezikian, David W. Dempster, et al.. (2013). Benefits and Risks of Bisphosphonate Therapy for Osteoporosis. Obstetrical & Gynecological Survey. 68(1). 37–39. 4 indexed citations
18.
Lewiecki, E. Michael, John P. Bilezikian, Cyrus Cooper, et al.. (2008). Proceedings of the Eighth Annual Santa Fe Bone Symposium, August 3–4, 2007. Journal of Clinical Densitometry. 11(2). 313–324. 17 indexed citations
19.
Recker, Robert R., Pierre D. Delmas, Johan Halse, et al.. (2007). Effects of Intravenous Zoledronic Acid Once Yearly on Bone Remodeling and Bone Structure. Journal of Bone and Mineral Research. 23(1). 6–16. 170 indexed citations
20.
McClung, Michael R., E. Michael Lewiecki, Stanley Cohen, et al.. (2006). Denosumab in Postmenopausal Women With Low Bone Mineral Density. Obstetrical & Gynecological Survey. 61(6). 384–386. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Felicia Cosman Breakdown of academic impact, for papers by Michael R. McClung Breakdown of academic impact, for papers by Ethel S. Siris Breakdown of academic impact, for papers by Dan Mellström Breakdown of academic impact, for papers by Eugène McCloskey Breakdown of academic impact, for papers by Nelson B. Watts Breakdown of academic impact, for papers by Jacques P. Brown Breakdown of academic impact, for papers by Christian Roux Breakdown of academic impact, for papers by Robert Lindsay Breakdown of academic impact, for papers by Paul D. Miller
Rankless by CCL
2026